Cite
HARVARD Citation
Casale, T. et al. (n.d.). CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study. Allergy. 70 (9), pp. 1160-1168. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Casale, T. et al. (n.d.). CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study. Allergy. 70 (9), pp. 1160-1168. [Online].